Potential driven electrochemical modification of tissue

US10939950B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10939950-B2
Application numberUS-201715841213-A
CountryUS
Kind codeB2
Filing dateDec 13, 2017
Priority dateMay 16, 2013
Publication dateMar 9, 2021
Grant dateMar 9, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of modifying a tissue includes providing an electrochemical reaction in the tissue by the use of an anodic electrode and a cathodic electrode wherein at least one of the anodic and cathodic electrodes is in contact with the tissue; and setting a concentration of electrochemically generated chemical agents that affect the tissue.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating a disease and/or condition in a subject, comprising: creating stress in a tissue of the subject to temporarily maintain a predetermined shape of the tissue; providing an electrochemical interaction in a constituent of the tissue; wherein providing the electrochemical interaction includes use of a working electrode, a reference electrode, and an auxiliary electrode; and wherein the electrodes are placed in a geometric arrangement effective for treating the disease and/or condition in the subject; wherein at least the working electrode is in contact with the tissue; acidifying the tissue to a pH range between 0-7 by acidification at the working electrode and subsequent diffusion of protons to the tissue; diffusing protons through the tissue; and re-equilibration of the tissue to physiological pH for sustained shape change of the tissue. 2. The method of claim 1 , wherein the tissue is at least one of ligament, tendon, cornea, ear drum, temporal mandibular joint, vocal cord, muscle, skin, nerve, brain tissue, and tumor. 3. The method of claim 1 , wherein the tissue is at least one of cartilage and bone. 4. The method of claim 1 , wherein providing the electrochemical interaction includes at least one of potential-driven electromechanical (EMR) and potential-driven electrochemical modification of tissue (PDEMT). 5. The method of claim 1 , wherein the subject is a human. 6. The method of claim 1 , wherein the subject is a rabbit. 7. The method of claim 1 , wherein providing the electrochemical interaction includes using a system having the working electrode, the reference electrode, and the auxiliary electrode; and a control system to apply a precise electrical potential to the tissue. 8. A method of shaping cartilage in a patient, comprising: creating stress in the cartilage to temporarily maintain a predetermined shape of the cartilage; providing at least one of a potential-driven electrochemical modification of tissue (PDEMT) device and a potential-driven electromechanical (EMR) device, wherein each device includes a working electrode, a reference electrode, and an auxiliary electrode, wherein the working electrode is in contact with the cartilage; and acidifying the cartilage to a pH range between 0-7 by acidification at the working electrode and subsequent diffusion of protons to the cartilage; using at least one of the PDEMT and EMR devices to shape the cartilage in the patient; and re-equilibrating the cartilage to physiological pH to sustain a predetermined shape of the cartilage. 9. The method of claim 8 , wherein shaping the cartilage includes at least one of shaping a facial structure, lengthening and/or tightening ligaments and tendons, and correcting vision in the patient. 10. The method of claim 8 , further comprising placing the PDEMT device or the EMR device in contact with the cartilage in a way to minimize pH gradients and/or Reactive Oxygen Species (ROS) generation. 11. The method of claim 8 , further comprising generating at least one of pH gradients and concentration gradients of added chemical agents in the cartilage by applying an electrochemical potential via pulsed or a custom waveform. 12. The method of claim 8 , wherein the PDEMT device or EMR device incorporates bipotentiostat and/or polypotentiostat technology. 13. A method of treating a cartilage malformation condition in a patient, comprising: creating stress in the cartilage to temporarily maintain a predetermined shape of the cartilage; providing a potential-driven electrochemical modification of tissue (PDEMT) device and a potential-driven electromechanical (EMR) device, wherein each device includes an anodic electrode and a cathodic electrode, wherein at least the anodic electrode is in contact with the cartilage; and acidifying the cartilage to a pH range between 0-7 by acidification at the anodic electrode and subsequent diffusion of protons to the cartilage; treating the patient by using at least one of the devices to shape the cartilage; and re-equilibrating the cartilage to physiological pH to sustain a predetermined shape of the cartilage. 14. The method of claim 13 , wherein the cartilage malformation condition is at least one of a nasal tip deformity, a deviated septum, a protuberant ear, and a stenotic trachea. 15. The method of claim 13 , wherein the PDEMT device and the EMR device incorporates bipotentiostat and/or polypotentiostat technology. 16. The method of claim 13 , wherein shaping the cartilage includes shaping cartilage in at least one of facial structure, lengthening and/or tightening ligaments and tendons, and correcting vision in the patient.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10939950B2 cover?
A method of modifying a tissue includes providing an electrochemical reaction in the tissue by the use of an anodic electrode and a cathodic electrode wherein at least one of the anodic and cathodic electrodes is in contact with the tissue; and setting a concentration of electrochemically generated chemical agents that affect the tissue.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification A61B18/1206. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).